Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT00651859 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: Bimatoprost 0.01% Ophthalmic Solution
DRUG: Bimatoprost 0.03% Ophthalmic Solution
DRUG: Bimatoprost Vehicle Ophthalmic Solution

Sponsor

Allergan